clinical trial · NCT03776968
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics
Metastatic Castration Resistant Prostate CancerHC1119
brief summary
This is a phase I study evaluating HC-1119 single-dose pharmacokinetics and effect of food on its pharmacokinetics in healthy Chinese adults. The study primary objective is to evaluate the HC-1119 pharmacokinetic characteristics and the effect of food on its pharmacokinetics in healthy Chinese males, subsequent to a single oral administration of HC-1119 with different doses in healthy Chinese males.
started
Oct 24, 2017
primary completion
Jan 15, 2018
completion
Jul 3, 2018
last updated
Oct 23, 2024
official title
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics in Healthy Chinese Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol